Sonnet BioTherapeutics Provides Fiscal Year 2021 Third Quarter Business and Earnings Update

Sonnet BioTherapeutics Provides Fiscal Year 2021 Third Quarter Business and Earnings Update

  • Expanded F H AB Intellectual Property Portfolio

  • Completed $15.9 million At-The-Market Financing

  • SON-1010 and SON-080 on track for IND submissions by calendar year end

PRINCETON, NJ / ACCESSWIRE / August 16, 2021 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (“Sonnet” or the “Company”), a biopharmaceutical company developing innovative targeted biologic drugs, announced today its financial results for the three months ended June 30th , 2021 and provided a business update.

“Throughout the quarter, we’ve continued to make several advancements towards the clinic with our proprietary Fully Human Albumin

Read more

Newtek Business Services Corp. Declares Third Quarter 2021

BOCA RATON, Fla., Aug. 10, 2021 (GLOBE NEWSWIRE) — Newtek Business Services Corp., (NASDAQ: NEWT), an internally managed business development company (“BDC”), today announced that its Board of Directors declared a third quarter 2021 cash dividend of $0.901 per share. The third quarter 2021 dividend is payable on September 30, 2021 to shareholders of record as of September 20, 2021. The payment of the third quarter 2021 dividend would represent a 55.2% increase over the third quarter 2020 dividend of $0.58 per share. With the payment of the third quarter 2021 dividend, the Company will have paid $2.10 per

Read more